New research supports MDMA use to treat PTSD
The realm of medicine is vast, and all the answers for the world’s problems lie somewhere; though, some are hidden better than others. Paid research studies have been conducted over the years looking into the possibility of MDMA aiding patients suffering from post-traumatic stress disorder. Post-traumatic stress disorder, or PTSD, is an ailment that, according to the National Center for PTSD, some develop after living through traumatic, high-stress, and/or life-threatening situations. Though commonly seen in military veterans, it can happen to anyone. Symptoms of PTSD include reliving the event in ones mind, avoiding places and situations that may resemble the event that troubles, negative feelings and beliefs, and hyperarousal.
Luckily, researchers based in California working for the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS), have had advancements in the studies pertaining to the use of MDMA to treat PTSD. Last week at the Psychedelic Science Conference in Oakland, CA, scientists with the group presented data that revealed controlled use of MDMA on patients that suffer from PTSD resulted in profound reduced effects of the disorder.
The trials, which were conducted by MAPS, took in 107 patients for the study. After receiving MDMA-assisted psychotherapy, 67% of those suffering reported back having zero PTSD-associated symptoms in a year’s time. The results of this study can only be the beginning of more research to come on the topic. The U.S. Food and Drug administration is on-board for further funding and research of the aid MDMA could present for patients.